Dermatology
Clinuvel Inc. focuses on vitiligo, with clinical research centered on skin pigmentation disorders and the restoration of repigmentation in affected patients.
- Vitiligo
- Skin pigmentation disorders
- Repigmentation therapies
The sponsor’s current clinical activity is concentrated in dermatologic treatment development, with attention to visible skin changes and pigment recovery.
Phototherapy
Its research landscape includes narrow-band ultraviolet B treatment approaches, reflecting interest in light-based interventions for pigment-related conditions.
- NB-UVB light treatment
- Light-based therapy
- Combination phototherapy
Clinical work in this area is directed toward evaluating how phototherapy supports visible skin repigmentation.
Melanocortin-related therapy
Clinuvel’s portfolio includes research interest in SCENESSE®, indicating focus on therapies linked to pigmentation biology and melanocyte function.
- SCENESSE®
- Melanocyte activation
- Pigment restoration
This area connects therapeutic development with mechanisms relevant to skin coloration and pigment recovery.
